Item 1.01 Entry into a Material Definitive Agreement.

On January 6, 2023, Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. (the "Company"), amended its existing office lease agreement for the Company's headquarters at 4978 Santa Anita Avenue, Temple City, California 91780 (the "Lease Amendment"). Under the terms of the Lease Amendment, the term of the lease was extended from January 31, 2023 to January 31, 2024 (the "Extended Term"). The Company's monthly rent payments will be $24,885.00 for the duration of the Extended Term. The Company will also be required to pay for utilities, upkeep and maintenance applicable to the leased premises.

A copy of the Lease Amendment is filed herewith as Exhibit 1.1, and is incorporated by reference as though fully set forth herein. The foregoing description of the agreement is not intended to be complete and is qualified in its entirety by the complete text of the Lease Amendment.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit   Description
  No.
1.1         Commercial Lease Addendum (II) by and between Fulgent Therapeutics LLC
          and E&E Plaza LLC
104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses